Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Huvudupphovsman: | |
---|---|
Övriga upphovsmän: | |
Materialtyp: | Lärdomsprov |
Språk: | English |
Publicerad: |
Brac University
2024
|
Ämnen: | |
Länkar: | http://hdl.handle.net/10361/23944 |